Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.

S-nitrosoglutathione reductase: an important regulator in human asthma.

Que LG, Yang Z, Stamler JS, Lugogo NL, Kraft M.

Am J Respir Crit Care Med. 2009 Aug 1;180(3):226-31. doi: 10.1164/rccm.200901-0158OC. Epub 2009 Apr 24.

2.

S-nitrosoglutathione supplementation to ovalbumin-sensitized and -challenged mice ameliorates methacholine-induced bronchoconstriction.

Foster MW, Yang Z, Potts EN, Michael Foster W, Que LG.

Am J Physiol Lung Cell Mol Physiol. 2011 Nov;301(5):L739-44. doi: 10.1152/ajplung.00134.2011. Epub 2011 Jul 22. Retraction in: Am J Physiol Lung Cell Mol Physiol. 2015 May 1;308(9):L981.

3.

Genetic variation in S-nitrosoglutathione reductase (GSNOR) and childhood asthma.

Wu H, Romieu I, Sienra-Monge JJ, Estela Del Rio-Navarro B, Anderson DM, Jenchura CA, Li H, Ramirez-Aguilar M, Del Carmen Lara-Sanchez I, London SJ.

J Allergy Clin Immunol. 2007 Aug;120(2):322-8. Epub 2007 Jun 1.

4.

Phenotype of asthmatics with increased airway S-nitrosoglutathione reductase activity.

Marozkina NV, Wang XQ, Stsiapura V, Fitzpatrick A, Carraro S, Hawkins GA, Bleecker E, Meyers D, Jarjour N, Fain SB, Wenzel S, Busse W, Castro M, Panettieri RA Jr, Moore W, Lewis SJ, Palmer LA, Altes T, de Lange EE, Erzurum S, Teague WG, Gaston B.

Eur Respir J. 2015 Jan;45(1):87-97. doi: 10.1183/09031936.00042414. Epub 2014 Oct 30. Erratum in: Eur Respir J. 2015 Jun;45(6):1763.

5.

Protection from experimental asthma by an endogenous bronchodilator.

Que LG, Liu L, Yan Y, Whitehead GS, Gavett SH, Schwartz DA, Stamler JS.

Science. 2005 Jun 10;308(5728):1618-21. Epub 2005 May 26.

6.

Effects of ozone on normal and potentially sensitive human subjects. Part I: Airway inflammation and responsiveness to ozone in normal and asthmatic subjects.

Balmes JR, Aris RM, Chen LL, Scannell C, Tager IB, Finkbeiner W, Christian D, Kelly T, Hearne PQ, Ferrando R, Welch B.

Res Rep Health Eff Inst. 1997 Jun;(78):1-37; discussion 81-99.

PMID:
9387195
7.

Pharmacologic inhibition of S-nitrosoglutathione reductase protects against experimental asthma in BALB/c mice through attenuation of both bronchoconstriction and inflammation.

Blonder JP, Mutka SC, Sun X, Qiu J, Green LH, Mehra NK, Boyanapalli R, Suniga M, Look K, Delany C, Richards JP, Looker D, Scoggin C, Rosenthal GJ.

BMC Pulm Med. 2014 Jan 10;14:3. doi: 10.1186/1471-2466-14-3.

8.

The role of S-nitrosoglutathione reductase (GSNOR) in human disease and therapy.

Barnett SD, Buxton ILO.

Crit Rev Biochem Mol Biol. 2017 Jun;52(3):340-354. doi: 10.1080/10409238.2017.1304353. Epub 2017 Apr 10. Review.

PMID:
28393572
9.

Influence of natural antigenic exposure on expiratory flows, methacholine responsiveness, and airway inflammation in mild allergic asthma.

Boulet LP, Turcotte H, Boutet M, Montminy L, Laviolette M.

J Allergy Clin Immunol. 1993 Apr;91(4):883-93.

PMID:
8473677
10.

Airway eosinophilic inflammation, epithelial damage, and bronchial hyperresponsiveness in patients with mild-moderate, stable asthma.

Oddera S, Silvestri M, Balbo A, Jovovich BO, Penna R, Crimi E, Rossi GA.

Allergy. 1996 Feb;51(2):100-7.

PMID:
8738515
11.

The effect of 1 ppm nitrogen dioxide on bronchoalveolar lavage cells and inflammatory mediators in normal and asthmatic subjects.

Jörres R, Nowak D, Grimminger F, Seeger W, Oldigs M, Magnussen H.

Eur Respir J. 1995 Mar;8(3):416-24.

12.

Modulation of mitochondrial activity by S-nitrosoglutathione reductase in Arabidopsis thaliana transgenic cell lines.

Frungillo L, de Oliveira JF, Saviani EE, Oliveira HC, Martínez MC, Salgado I.

Biochim Biophys Acta. 2013 Mar;1827(3):239-47. doi: 10.1016/j.bbabio.2012.11.011. Epub 2012 Nov 29.

14.

Discovery of s-nitrosoglutathione reductase inhibitors: potential agents for the treatment of asthma and other inflammatory diseases.

Sun X, Wasley JW, Qiu J, Blonder JP, Stout AM, Green LS, Strong SA, Colagiovanni DB, Richards JP, Mutka SC, Chun L, Rosenthal GJ.

ACS Med Chem Lett. 2011 Mar 11;2(5):402-6. doi: 10.1021/ml200045s. eCollection 2011 May 12.

15.

Elevated bronchoalveolar lavage fluid histamine levels in allergic asthmatics are associated with increased airway obstruction.

Jarjour NN, Calhoun WJ, Schwartz LB, Busse WW.

Am Rev Respir Dis. 1991 Jul;144(1):83-7.

PMID:
2064143
16.

Structure-activity relationship of pyrrole based S-nitrosoglutathione reductase inhibitors: carboxamide modification.

Sun X, Qiu J, Strong SA, Green LS, Wasley JW, Blonder JP, Colagiovanni DB, Stout AM, Mutka SC, Richards JP, Rosenthal GJ.

Bioorg Med Chem Lett. 2012 Mar 15;22(6):2338-42. doi: 10.1016/j.bmcl.2012.01.047. Epub 2012 Feb 2.

PMID:
22342142
17.
18.

Health effects of acute exposure to air pollution. Part I: Healthy and asthmatic subjects exposed to diesel exhaust.

Holgate ST, Sandström T, Frew AJ, Stenfors N, Nördenhall C, Salvi S, Blomberg A, Helleday R, Söderberg M.

Res Rep Health Eff Inst. 2003 Dec;(112):1-30; discussion 51-67.

PMID:
14738208
19.

Greater ozone-induced inflammatory responses in subjects with asthma.

Scannell C, Chen L, Aris RM, Tager I, Christian D, Ferrando R, Welch B, Kelly T, Balmes JR.

Am J Respir Crit Care Med. 1996 Jul;154(1):24-9.

PMID:
8680687
20.

Analysis of a Panel of 48 Cytokines in BAL Fluids Specifically Identifies IL-8 Levels as the Only Cytokine that Distinguishes Controlled Asthma from Uncontrolled Asthma, and Correlates Inversely with FEV1.

Hosoki K, Ying S, Corrigan C, Qi H, Kurosky A, Jennings K, Sun Q, Boldogh I, Sur S.

PLoS One. 2015 May 26;10(5):e0126035. doi: 10.1371/journal.pone.0126035. eCollection 2015.

Supplemental Content

Support Center